Diagnosis & Disease Information

Pharmacogenetic Testing: Does it Improve Therapy in Patients With MDD?

By

Lauren Nolan, MMSc, PA-C

Tia M. Solh, MT (ASCP), MSPAS, PA-C

September 17, 2020

Testing for genetic variants may allow clinicians to predict how patients with major depressive disorder metabolize antidepressants.

Next post in Medicine

Only factor VIII trough level and prophylactic treatment showed associations with joint health in univariate analysis.

Fostering Trust Between Parents of Children With Cancer and Physicians